Pacira BioSciences Reports Second Quarter 2020 Financial Results and Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Pacira BioSciences Reports Second Quarter 2020 Financial Results and Business Update

Pacira Pharma (PCRX) Tops Q2 EPS by 3c, Revenues Beat

August 6, 2020 8:04 AM EDT

Pacira Pharma (NASDAQ: PCRX) reported Q2 EPS of $0.12, $0.03 better than the analyst estimate of $0.09. Revenue for the quarter came in at $75.51 million versus the consensus estimate of $72.46 million.

Second Quarter 2020 Financial Results

Total revenues were $75.5 million in the second quarter of 2020, a 26% decrease versus the $102.6 million reported for the second... More